We can't find the internet
Attempting to reconnect
12040.1;5 PFLS-LS
Method comparability as prerequisite for biomarker selection - feasibility study
Résumé
Method comparability as prerequisite for biomarker selection - feasibility study
Textes supplémentaires
Abstract
Together FHNW and ProteoMediX will translate verified research results to a clinically applicable diagnostic prototype test for the more accurate detection of prostate cancer addressing a clear unmet medical need. The final test will be based on a unique signature of protein analytes. This proposal comprises a feasibility study using an innovative biosensor-based approach to bridge the gap between mass spectrometrybased verification and immunoassay-based validation of promising diagnostic markers selected from a bundle of candidates, i.e. protein analytes. This feasibility study is key for entering full development aimed at bringing out ProteoMediX¿s first promising product with prognosticated peak sales of 20 million CHF per year.
Participants
Daniel Gygax
Kontaktperson
daniel.gygax@fhnw.ch
Fachhochschule Nordwestschweiz Daniel Gygax Gründenstrasse 40 Hochschule für Life Sciences 4132 Muttenz BL CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2011-01-31
- Date de fin
- 2012-09-16
- Coûts totaux approuvés
- CHF 92057.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Nicht aufteilbare / nicht zuteilbare Forschung
Disciplines de recherche
- T490 Biotechnology 100.0%